QS Investors’s Exact Sciences EXAS Stock Holding History

QS Investors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$314K	Hold	2,518	–	–	﹤0.01%	931
2021 Q1	$332K	Buy	2,518 +300	+14%	+$41.1K	﹤0.01%	950
2020 Q4	$294K	Buy	2,218 +218	+11%	+$26.4K	﹤0.01%	1003
2020 Q3	$204K	Sell	2,000 -1,000	-33%	-$86.4K	﹤0.01%	1070
2020 Q2	$261K	Hold	3,000	–	–	﹤0.01%	1069
2020 Q1	$174K	Sell	3,000 -315	-10%	-$25.6K	﹤0.01%	1123
2019 Q4	$317K	Sell	3,315 -985	-23%	-$86.6K	﹤0.01%	1065
2019 Q3	$389K	Hold	4,300	–	–	﹤0.01%	1020
2019 Q2	$508K	Buy	4,300 +1,800	+72%	+$181K	0.01%	964
2019 Q1	$217K	Sell	2,500 -18	-0.7%	-$1.53K	﹤0.01%	1195
2018 Q4	$159K	Hold	2,518	–	–	﹤0.01%	1206
2018 Q3	$199K	Sell	2,518 -77,614	-97%	-$5.06M	﹤0.01%	1206
2018 Q2	$4.79M	Buy	80,132 +5	+0%	+$269	0.05%	301
2018 Q1	$3.23M	Buy	80,127 +77,564	+3,026%	+$3.78M	0.03%	404
2017 Q4	$135K	Buy	2,563 +45	+2%	+$2.4K	﹤0.01%	1325
2017 Q3	$119K	Hold	2,518	–	–	﹤0.01%	1383
2017 Q2	$89K	Buy	2,518 +18	+0.7%	+$556	﹤0.01%	1403
2017 Q1	$59K	Buy	+2,500	New	+$49.5K	﹤0.01%	1471

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

QS Investors's EXAS Position: Q2 2021 in Review

QS Investors held its Exact Sciences (EXAS) position steady in Q2 2021 at 2,518 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #931.

QS Investors first reported a position in EXAS in Q1 2017 and has held it in 18 quarters since. The position peaked at $4.79M in Q2 2018. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

QS Investors held 2,518 shares of Exact Sciences worth $314K as of Q2 2021.
QS Investors left its Exact Sciences share count unchanged in Q2 2021.
Exact Sciences made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #931 holding.
QS Investors first reported a position in Exact Sciences in Q1 2017 and has held it in 18 quarters since.
QS Investors's Exact Sciences position peaked at $4.79M in Q2 2018.
623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.